Survival of patients with prostate cancer depends
on a number of factors. One of the most important factors is early
diagnosis. One of the first indications that a man may have prostate
cancer is a difficulty to urinate.
Enlargement of the prostate causes urinary symptoms which motivates
the patient to see a urologist. During this initial visit with the
urologist an interview to obtain a medical history and a digital
rectal examination (DRE) allows for assessment of size, texture
and uniformity of the prostate gland.
A blood sample will be obtained for a Prostate-Specific Antigen
(PSA) test. This test allows for the detection of prostatic disease.
If prostate cancer is suspected, the urologist may
choose one or all of these procedures to confirm his suspicions:
Biopsy: Samples of prostate tissue are
obtained using a thin needle, generally 6 to 12 specimens
are analysed.
MRI or scanner:
Imaging of body parts to detect an extension of the cancer
to other organs (lymph nodes, liver, etc.)
Bonescan:
Imaging by injection, usually done to rule out bone metastasis.
Early diagnosis and treatment can guarantee to the
patient a longer and more normal life.